Company Profile
Veracyte Stock Price, News & Analysis
- Ticker:
- VCYT
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
46.15 USD (0.00%)
Close
Last updated: August 6, 2026
3.81B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, VCYT was little changed and closed at $46.15. No new same-company headline was identified in the current news window.
Company overview
Business overview
Veracyte is a diagnostics company focused on genomic testing for cancer and other high-value clinical decisions. Its products help physicians make more informed treatment and biopsy decisions.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Veracyte sits in molecular diagnostics and precision medicine.
Business Model Characteristics
The company depends on test volume, reimbursement, and the expansion of its oncology and pulmonary diagnostics franchises.
Position Within the Biotechnology Landscape
Veracyte is a diagnostics platform name whose stock moves more on adoption and reimbursement than on drug-development catalysts.
Future catalysts
Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption. The company improves when recurring testing and reimbursement keep expanding.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Veracyte (VCYT)?
Veracyte (VCYT) most recently closed at 46.15 USD, a 0.00% move versus the previous session.
What is the market cap of Veracyte (VCYT)?
Veracyte currently has a market capitalization of 3.81B USD on BioPharmSignal.
What does Veracyte do?
Veracyte is a diagnostics company focused on genomic testing for cancer and other high-value clinical decisions. Its products help physicians make more informed treatment and biopsy decisions.
On which exchange is VCYT stock listed?
Veracyte (VCYT) is associated with NASDAQ, United States, MedTech.
What is Veracyte?
Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption.
Which conditions is Veracyte targeting with Veracyte?
Veracyte is associated with cancer therapeutics based on its company overview and current catalyst commentary.
How does Veracyte describe recent progress with Veracyte?
Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption.
What is Afirma?
Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption.